Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer

American Journal of Gastroenterology

Volumn 93, Issue 10, 1998, Pages 1967-1971

  Suehara, Nobuhiro ^a   Mizumoto, Kazuhiro ^a   Kusumoto, Masahiro ^a   Niiyama, Hideaki ^a   Ogawa, Takahiro ^a   Yamaguchi, Koji ^a   Yokohata, Kazunori ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMYLASE; TELOMERASE;

ADULT; ALCOHOLISM; ARTICLE; BACKACHE; CANCER DIAGNOSIS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME ACTIVITY; EPIGASTRIC PAIN; HUMAN; HUMAN TISSUE; MALE; PANCREAS CANCER; PANCREAS JUICE; PANCREATICODUODENECTOMY; PANCREATITIS; PRIORITY JOURNAL;

CARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; MALE; MIDDLE AGED; PANCREATIC JUICE; PANCREATIC NEOPLASMS; TELOMERASE; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032431630     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00557.x     Document Type: Article

References (11)

1. 1. Tada M, Omata M, Kawai S, et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993;53:2472-4.
2. 2. Ishimaru S, Itoh M, Hanada K, et al. Immunohistochemical detection of p53 protein from pancreatic duct brushings in patients with pancreatic carcinoma. Cancer 1996;77:2233-9.
3. 3. Yanagisawa A, Ohtake K, Ohashi K, et al. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 1993;53:953-6.
4. 4. Yanagisawa A, Kato Y, Ohtake K, et al. c-Ki-ras point mutations in ductectatic-type mucinous cystic neoplasms of the pancreas. Jpn J Cancer Res 1991;82:1057-60.
5. 5. Berrozpe G, Schaeffer J, Peinado MA, et al. Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int J Cancer 1994;58:185-91.
6. 6. Mizumoto K, Suehara N, Muta T, et al. Semi-quantitative analysis of telomerase in pancreatic ductal adenocarcinoma. J Gastroenterol 1996; 31:894-7.
7. 7. Suehara N, Mizumoto K, Muta T, et al. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. Clin Cancer Res 1997;3:993-8.
8. 8. Suehara N, Mizumoto K, Tanaka M, et al. Telomerase activity in pancreatic juice discriminates ductal carcinoma from adenoma and pancreatitis. Clin Cancer Res 1997;3:2479-83.
9. 9. Ikeda S, Matsumoto S, Yoshimoto H, et al. Endoscopic balloon catheter pancreatography using catheter retaining technique. Stomach Intestine 1984;19:1231-42 (in Japanese with an English abstract).
10. 10. Beahrs OH, Henson DE, Hutter RVP, et al. (eds.) Pancreas. Manual for staging of cancer, ed. 4. American Joint Committee on Cancer. Philadelphia: JB Lippincott Co, 1992.
11. 11. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-5.